ArticleBMC cancer2017

Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38.

Katharina Gohr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.